Jane Street’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.63M Buy
310,700
+79,200
+34% +$755K ﹤0.01% 4592
2025
Q4
$2.81M Sell
231,500
-100
-0% -$1.22K ﹤0.01% 4156
2025
Q3
$2.71M Buy
231,600
+22,500
+11% +$269K ﹤0.01% 4401
2025
Q2
$1.94M Buy
+209,100
New +$1.64M ﹤0.01% 4463
2025
Q1
Sell
-33,100
Closed -$283K 10269
2024
Q4
$283K Buy
33,100
+14,000
+73% +$137K ﹤0.01% 7832
2024
Q3
$166K Buy
+19,100
New +$157K ﹤0.01% 8764
2024
Q1
Sell
-12,000
Closed -$53.5K 9822
2023
Q4
$53.5K Buy
12,000
+300
+3% +$887 ﹤0.01% 8766
2023
Q3
$36.7K Sell
11,700
-78,900
-87% -$323K ﹤0.01% 8217
2023
Q2
$467K Buy
+90,600
New +$539K ﹤0.01% 6420
2022
Q1
Sell
-22,600
Closed -$158K 10818
2021
Q4
$158K Sell
22,600
-21,000
-48% -$163K ﹤0.01% 8969
2021
Q3
$436K Sell
43,600
-1,600
-4% -$18K ﹤0.01% 7540
2021
Q2
$641K Buy
+45,200
New +$687K ﹤0.01% 6772
2021
Q1
Sell
-16,600
Closed -$344K 9445
2020
Q4
$344K Buy
+16,600
New +$247K ﹤0.01% 6229
2020
Q3
Sell
-132,900
Closed -$1.11M 7680
2020
Q2
$1.11M Buy
132,900
+113,100
+571% +$750K ﹤0.01% 3915
2020
Q1
$98K Buy
+19,800
New +$97.8K ﹤0.01% 4942

Other funds holding OCUL